CVE-2026-21974
low-risk
Published 2026-01-20
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Do I need to act?
-
0.04% chance of exploitation
EPSS score — low exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
5
CVSS 5.3/10
Medium
NETWORK
/ LOW complexity
Affected Products (1)
Life Sciences Central Designer
Affected Vendors
References (1)
Vendor Advisory
https://www.oracle.com/security-alerts/cpujan2026.html
26
/ 100
low-risk
Severity
21/34 · High
Exploitability
0/34 · Minimal
Exposure
5/34 · Minimal